Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension

Hypertension

Volumn 26, Issue 6 I, 1995, Pages 863-868

  García, Carlos E ^a   Kilcoyne, Crescence M ^a   Cardillo, Carmine ^a   Cannon III, Richard O ^a   Quyyumi, Arshed A ^a   Panza, Julio A ^a,b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

acetylcholine; blood vessels; endothelium; endothelium derived factors; free radicals; hypertension, essential

Indexed keywords

ACETYLCHOLINE; COPPER ZINC SUPEROXIDE DISMUTASE; NITROPRUSSIDE SODIUM;

ADULT; ARTERY BLOOD FLOW; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME MECHANISM; ENZYME REGULATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION;

EID: 0028801342     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.26.6.863     Document Type: Article

References (53)

1. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
2. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762-1767.
3. Hirooka Y, Imaizumi T, Masaki H, Ando S, Harada S, Momohara M, Takeshita A. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Hypertension. 1992;20:175-180.
4. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992;10:1025-1031.
5. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468-1474.
6. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from retractor penis is inorganic nitrate and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte PM, ed. Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomie Nerves and Endothelium. New York, NY: Raven Press Publishers; 1988: 401-414.
7. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
8. Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res. 1987;61:866-879.
9. Griffith TM, Edwards DH, Lewis MJ, Newby AC, Henderson AH. The nature of endothelium-derived relaxant factor. Nature. 1984; 308:645-647.
10. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
11. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
12. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2: 997-1000.
13. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278-281.
14. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 1993;11:1375-1380.
15. Manning RD Jr, Hu L, Mizelle HL, Montani JP, Norton MW. Cardiovascular responses to long-term blockade of nitric oxide synthesis. Hypertension. 1993;22:40-48.
16. Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 1994;89:2035-2040.
17. Rubanyi GM, Vanhoutte PM. Superoxide anion and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 1986; 250:H822-H827.
18. Gryglewski RJ. Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454-456.
19. Mügge A, Elwell JH, Peterson TE, Harrison DG. Release of intact endothelium-dependent relaxing factor depends on endothelial superoxide dismutase activity. Am J Physiol. 1991;260:C219-C225.
20. Omar BA, Flores SC, McCord JM. Superoxide dismutase: pharmacological developments and applications. Adv Pharmacol. 1992;23: 109-161.
21. Nakazono K, Watanabe N, Matsuno K, Sasak J, Sato T. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A. 1991;88:1045-1048.
22. Wei EP, Kontos HA, Christman CW, DeWitt DS, Povlishock JT. Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilatation after acute hypertension. Circ Res. 1985;57:781-787.
23. Whitney RJ. Measurement of changes in human limb volume by means of a mercury-in-rubber strain gauge. J Physiol (Lond). 1948; 108:5P-6P.
24. Greenfield ADM, Whitney RJ, Mowbray JF. Methods for the investigation of peripheral blood flow. Br Med Bull. 1963;19:101-109.
25. Hokanson DE, Sumner DS, Strandness DE Jr. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng. 1975;22:25-29.
26. Kerslake DM. The effect of the application of an arterial occlusion cuff to the wrist on the blood flow in the human forearm. J Physiol (Lond). 1949;109:451-457.
27. Bohme E, Graf H, Schultz G. Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP-formation in smooth muscle and platelets. Adv Cycl Nucl Res. 1978;9:131-143.
28. Kukovetz WR, Holtzmann S, Wurm A, Poch G. Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle. Naunyn Schmiedebergs Arch Pharmacol. 1979;310: 129-138.
29. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
30. Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res. 1983;53:557-573.
31. McCord JM, Fridovich I. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244: 6049-6055.
32. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygen-derived free radicals arc augmented in aorta of the spontaneously hypertensive rat. Hypertension. 1989;13:859-864.
33. Sharma RC, Crawford DW, Kramsch DM, Sevanian A, Jiao Q. Immunolocalization of native antioxidant scavenger enzymes in early hypertensive and atherosclerotic arteries: role of oxygen free radicals. Arterioscler Thromb. 1992;12:403-415.
34. Sagar S, Kallo IJ, Nalini K, Ganguly NK, Sharma BK. Oxygen free radicals in essential hypertension. Mol Cell Biochem. 1992;111: 103-108.
35. Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radie Res Commun. 1993; 19:59-66.
36. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normals and in patients with essential hypertension. Circulation. 1993;87:1475-1481.
37. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level. J Am Coll Cardiol. 1994;23:1610-1616.
38. Panza JA, García CE, Kilcoyne CM, Quyyumi AA, Cannon RO. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation. 1995;91:1732-1738.
39. 2+ signaling mechanisms of vascular endothelial cells and their role in oxidant-induced endothelial cell dysfunction. Am J Physiol. 1992;262:H1617-H1630.
40. Abou-Donia MM, Daniels JA, Nichol CA, Viverso HL. Regulation of adrenocortical guanosine triphosphate cyclohydrolase and tetrahydrobiopterin in normal and spontaneously hypertensive rats. In: Blair JA, ed. Chemistry and Biology of Pteridines. New York, NY: Walter de Gruyter & Co; 1983:783-787.
41. Consentino F, Katusic ZS. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation. 1995;91:139-144.
42. Bonnardeux A, Nadaud S, Charru A, Jeunemaitre X, Corvol P, Soubrier F. Lack of evidence for linkage of endothelial cell nitric oxide synthase gene to essential hypertension. Circulation. 1995;91: 96-102.
43. White CW, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MM. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci U S A. 1994;91:1044-1048.
44. Meredith IT, Todd JA, Yeung AC, Lieberman EH, Dyce MC, Gonenne A, Uehata A, Selwyn AP, Ganz P. Superoxide dismutase restores endothelial vasodilator function in human coronary arteries in vivo. Circulation. 1993;88(suppl I):I-467. Abstract.
45. Jolly SR, Kane WJ, Bailie MB, Abrams GD, Lucchesi BR. Canine myocardial reperfusion injury: its reduction by the combined administration of superoxide dismutase and catalase. Circ Res. 1984;54:277-285.
46. Werns SW, Shea MJ, Driscoll EM, Cohen C, Abrams GD, Pitt B, Lucchesi BR. The independent effects of oxygen radical scavengers on canine infarct size: reduction by superoxide dismutase but not catalase. Circ Res. 1985;56:895-898.
47. Chambers DE, Parks DA, Patterson G, Roy RS, McCord JM, Yoshida S, Parmley L, Downey JM. Xanthine oxidase as a source of free radical in myocardial ischemia. J Mol Cell Cardiol. 1985;17: 145-152.
48. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of spontaneously hypertensive rats. Hypertension. 1986;8:344-348.
49. Tesfamariam B, Halpen W. Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. Hypertension. 1988;11:440-444.
50. Diederich D, Yang Z, Buhler FR, Luscher TF. Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve the cyclooxygenase pathway. Am J Physiol. 1990;258: H445-H451.
51. 2-receptor antagonists inhibit endothelium-dependent contractions. Hypertension. 1990;15:699-703.
52. Taddei S, Virdis A, Mattel P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929-933.
53. Auch-Schwelk W, Katusic Z, Vanhoutte PM. Nitric oxide inactivates endothelium-derived contracting factors in the rat aorta. Hypertension. 1992;19:442-445.